上睑下垂
苦参素
炎症
肺纤维化
纤维化
医学
巨噬细胞
免疫学
药理学
趋化因子
肺
炎症反应
癌症研究
细胞因子
白藜芦醇
特发性肺纤维化
作者
Qingxiang Liu,Xiaoyun Cheng,Xiangyu Zhang,Tingting Yao,Guoliang Jiang,Jianhua Zeng,Wenjian Zhang,Mao Jiang,Yijun He,何露娟,Feng Zhao,Jie Meng,龙灵芝
标识
DOI:10.1016/j.ejphar.2026.179491
摘要
Occupational silica exposure is a critical health hazard, leading to silicosis, a debilitating lung disease characterized by persistent inflammation and progressive fibrosis, in which macrophages play a pivotal pathogenic role. This study aimed to evaluate the protective effects of piceatannol (PIC), a natural stilbenoid, against silica-induced pulmonary inflammation and fibrosis, and to elucidate its underlying molecular mechanisms. In vivo, PIC administration significantly alleviated acute pulmonary inflammation in a 7-day silica exposure model and reduced chronic fibrosis in a 28-day model, along with reduced macrophage infiltration into lung tissue. In vitro, PIC suppressed the secretion of pro-inflammatory and pro-fibrotic cytokines from silica-stimulated macrophages and inhibited the subsequent activation of fibroblasts in the co-culture system. Transcriptomic and mechanistic analyses revealed that PIC inhibited the SYK/PKCδ/CARD9-BCL10-MALT1/NF-κB signaling axis and downstream NLRP3 inflammasome-mediated pyroptosis in macrophages. Importantly, the therapeutic effects of PIC were reversed by the PKC agonist phorbol 12-myristate 13-acetate (PMA), supporting the involvement of this pathway. These findings identify PIC as a potential therapeutic agent for silicosis that targets the SYK/PKCδ/CARD9-BCL10-MALT1/NF-κB axis in macrophages and provide new insights into mitigating the pathogenic processes of silica-induced lung disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI